Skip to main content
MR

Marc Radke

Editor-in- Chief, DAS INVESTMENT

DAS INVESTMENT

m***@dasinvestment.com Upgrade
Pro only
Hamburg, Hamburg, Germany

Published In

Recent Article

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984 | Journal of Clinical Oncology

Upgrade for article links
1 total articles published · Editor-in- Chief